Basic Information
| LncRNA/CircRNA Name | CDKN2B-AS |
| Synonyms | NA |
| Region | NA |
| Ensemble | NA |
| Refseq | NA |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | Paclitaxel | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | endometrial cancer |
| ICD-0-3 | NA |
| Methods | qPCR |
| Sample | EC tissues, cell lines |
| Expression Pattern | up-regulated |
| Function Description | Firstly, CDKN2B-AS gene was highly expressed in EC tissues and cell lines. |
| Pubmed ID | 30761271 |
| Year | 2019 |
| Title | Long Non-coding RNA CDKN2B Antisense RNA 1 Gene Contributes to Paclitaxel Resistance in Endometrial Carcinoma. |
External Links
| Links for CDKN2B-AS | GenBank HGNC NONCODE |
| Links for endometrial cancer | OMIM COSMIC |